Autres langues ResMed Inc. Australian S.E.

Actions

Marché Fermé - Australian S.E. Autres places de cotation 08:10:22 23/05/2024			Varia. 5j.	Varia. 1 janv.
32,85 ^AUD	+0,95 %		-0,76 %	+29,13 %

14/05	Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM
10/05	Un initié de Resmed a vendu des actions pour une valeur de 2 747 810 $, selon un récent dépôt auprès de la SEC	MT

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy	15:05
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy	16/05
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	10/05
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	09/05
ResMed Announces Participation in the RBCCM Global Healthcare Conference	07/05
ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript	30/04
Morgans rates RMD as Add	29/04
ResMed Silences The Doubters	29/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	26/04
Top Midday Gainers	26/04
Sector Update: Health Care Stocks Higher in Afternoon Trading	26/04
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	26/04
Sector Update: Health Care	26/04
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	26/04
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	26/04
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	26/04
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	26/04
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	26/04
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	25/04
ResMed: Fiscal Q3 Earnings Snapshot	25/04

Aucun résultat pour cette recherche

ResMed, Inc. : le marchand de sommeil poursuit son avancée

Le 08 décembre 2023 à 18:04